Tollys
  • About Us
    • Company
    • Board of Directors
    • Management
    • Scientific Advisory Board
  • Science
    • Immuno-oncology
    • TLR3 Science
    • Publications & Posters
  • Product
    • TL-532
    • Intellectual property
  • Pipeline
    • TLR3+ Cancers
  • News
  • Careers
  • Contact
Select Page

Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis.

by SmallStories | Aug 29, 2018 | Publications

Alkurdi L, Virard F, Vanbervliet B, Weber K, Toscano F, Bonnin M, Le Stang N, Lantuejoul S, Micheau O, Renno T, Lebecque S, Estornes Y.

Cell Death Dis. 2018 Aug 29; 9(9):874

Recent Posts

  • TL-532, a novel rationally designed TLR3 agonist, induces tumor-specific apoptosis, immune simulation, life-long anti-tumor auto-vaccination, and reverses resistance to immune checkpoint inhibitors
  • Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532
  • TL-532 specific TLR3 agonist induces lifelong anti-tumor autovaccination, cross-immunity against unrelated cancer and reverses resistance to immune checkpoint inhibitors
  • TL-532 specific TLR3 agonist induces lifelong anti-tumor autovaccination, cross-immunity against unrelated cancer and reverses resistance to immune checkpoint inhibitors
  • TOLLYS : la phase clinique bientôt en vue (La Gazette du Laboratoire – Juillet 2022)

Recent Comments

    Archives

    • October 2022
    • September 2022
    • July 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • October 2020
    • July 2020
    • May 2020
    • December 2019
    • November 2019
    • August 2018
    • June 2016
    • January 2015
    • September 2012
    • March 2011
    • December 2007
    • August 2007
    • April 2006
    • September 1991
    • July 1980

    Categories

    • News
    • Publications

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Design by Small Stories ©2019